Works matching IS 20406207 AND DT 2018 AND VI 9 AND IP 3

Results: 1
    1

    Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study.

    Published in:
    Therapeutic Advances in Hematology, 2018, v. 9, n. 3, p. 65, doi. 10.1177/2040620718756603
    By:
    • Kuo, Ching-Yuan;
    • Wang, Po-Nan;
    • Hwang, Wen-Li;
    • Tzeng, Cheng-Hwai;
    • Bai, Li-Yaun;
    • Tang, Jih-Luh;
    • Chang, Ming-Chih;
    • Lin, Sheng-Fung;
    • Chen, Tsai-Yun;
    • Chen, Yeu-Chin;
    • Tan, Tran-Der;
    • Hsieh, Chih-Yi;
    • Lin, Chinjune;
    • Lai, Clinton;
    • Miljkovic, Darko;
    • Chang, Cheng-Shyong
    Publication type:
    Article